Sigachi Industries informs about press release

21 Jan 2026 Evaluate
Sigachi Industries has informed that Sigachi Industries, a leading Indian pharmaceutical company, today announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) combination comprising Vanzacaftor, Tezacaftor, and Deutivacaftor. A press release to this extent is enclosed.

The above information is a part of company’s filings submitted to BSE.

Sigachi Industries Share Price

20.44 -1.85 (-8.30%)
27-Jan-2026 10:52 View Price Chart
Peers
Company Name CMP
BASF India 3569.75
Tata Chemicals 710.30
SRF 2690.00
Pidilite Inds. 1440.65
Deepak Nitrite 1528.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×